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Echocardiography has evolved to be an important tool in the assessment of patients with hypertrophic and restric-
tive cardiomyopathy. Hypertrophic cardiomyopathy (HCM) is a common inherited cardiovascular disease and the 
most frequent cause of sudden death in young athletes. HCM causes functional disability from heart failure and 
stroke. Therefore, the identification of patients with HCM is a challenge. 
Two-dimensional echocardiography is the usual initial method of diagnosis. Echocardiography can be used to con-
firm the heart dimension, the pattern of ventricular hypertrophy, systolic and diastolic function and the severity 
of the outflow gradient. Echocardiographic criteria for diagnosis of HCM have been proposed1,2. The World Health 
Organization defines restrictive cardiomyopathy (RCM) as a myocardial disease characterized by restrictive filling 
and reduced diastolic volume of either or both ventricles with normal or almost normal systolic function and wall 
thickness. Clinically, RCM is difficult to distinguish from constrictive pericarditis, which is treatable. Echocardi-
ography and cardiac magnetic resonance imaging (MRI) have been reported to be comparable in their ability to 
differentiate RCM from constrictive paricarditis. Compared with MRI, echocardiography may be restricted by by 
inadequate echo window, and pericardial thickness can be overlooked.3 The presentation will be shown current 
and emerging methodology approach and echocardiographic tools used in contemporary echocardiography in the 
diagnosis of HCM and RCM and differentiation from mimicking diseases, assessment of prognosis, and managing 
therapeutic approach.
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